Stada Strikes Deal To Launch ViruProtect In Nordics
Executive Summary
Stada to launch innovative common cold spray ViruProtect in four Nordic markets in 2021 after striking a new agreement with Sweden's Enzymatica.
You may also be interested in...
Consumer Health Business News: Rebrands for Takeda OTC And Reckitt, DSM Acquires, Enzymatica Raises Funds
A round-up of the latest consumer health industry news: Takeda completes the sale of its Japanese OTC business, which has rebranded as Alinamin; Reckitt drops the "Benckiser" from its name to signal new approach; Enzymatica looks to raise funds as COVID continues to bite; and Royal DSM expands its portfolio through a new deal with Amyris.
EU Business Round-Up: HRA Pharma Strikes Spain Deal, Enzymatica Expands Production
Latest EU business news: HRA Pharma strikes distribution deal with Vemedia for Spain; and Enzymatica increases ColdZyme production to meet growing demand.
Stada Takes ViruProtect To Russia And Beyond
Germany's Stada has expanded its deal with Enymatica to take the latter's ViruProtect common cold brand into Russia, the CIS and beyond.